Innovative Industrial Properties, Inc. IIPR
IIPR upgrades to buy as Q2 2026 results show the first positive YoY revenue growth in recent quarters at +0.7%, alongside a massive AFFO beat of $1.83 versus $1.02 consensus, signaling operational stabilization after FY2025's 13.8% revenue decline and 28.8% EPS contraction. Operating income recovered sharply to $43.9M in Q2 from $32.5M in Q1, while low leverage ($393.7M debt against $1.85B equity), a 12.6x P/E, completed life-s sciences diversification, and balance sheet refinancing provide a constructive setup.
Persistent insider buying (net 297,665 shares over 24 months) and a marginally positive smart money score of 0.0014 as of the quarter ended 2026-06-30 corroborate the inflection thesis.
What could go wrong
- Margin compression trend. Gross margin declined from 97.8% in FY2021 to 88.7% in FY2025 and operating margin compressed from 66.2% to 46.7% over the same period, reflecting tenant stress and lease modifications that could persist.
- Cannabis regulatory overhang. All tenants are state-licensed cannabis operators; adverse regulatory changes, continued price compression in cannabis markets, or tenant defaults could reverse the Q2 stabilization.
- Revenue recovery fragility. Q2 2026 YoY revenue growth was barely positive at +0.7% following quarters of double-digit declines (Q3 2025 -15.5%, Q2 2025 -21.2%); one quarter of stabilization does not confirm a sustained trend.
- Technical weakness. Stock at $56.92 trades below its 50-day MA of $60.18 with RSI at 43.6, suggesting near-term momentum remains soft despite the MACD histogram turning slightly positive.
What would change my mind
Where this comes from: quarterly_results Q2 2026 · earnings_surprises period_end 2026-08-03 · derived_metrics FY2025 · quarterly_results Q2 and Q1 2026. Orin's read on IIPR; not advice.
Twelve months actual closes to 2026-09-24 · actual filings
50-day average 200-day average · volume below
On file
All IIPR filingsLargest holders · 13F Q2 2026
Money flow| Filer | Position | Of fund |
|---|---|---|
| Vanguard Portfolio Management | $174.7M | 0.0% of fund |
| State Street | $104.0M | 0.0% of fund |
| Vanguard Capital Management | $80.1M | 0.0% of fund |
| Charles Schwab Investment Management | $40.2M | 0.0% of fund |
| Mirae Asset Global Etfs Holdings | $32.5M | 0.0% of fund |
| Invesco | $30.8M | 0.0% of fund |
49 filers · quarter ended Q2 2026 · positions, not flows
Insiders, last 24 months: 42 Form 4 filings, net −$1.3M. Of the 42 on hand, 5 were open-market purchases and 2 sales— the rest are grants, option exercises and tax withholding.
Ask Orin about IIPR
Orin answers questions about IIPR from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.
Start 3 free days →Where it trades
| Metric | Now | Own median | Sector |
|---|---|---|---|
| P/E | 12.3× | — | 56.8× |
| EV/EBITDA | 8.5× | — | — |
| P/S | 6.12× | — | — |
| P/B | 0.9× | — | — |
-3.0%
free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $0.2B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.
What Wall Street published
$85
$44 – $150 · +52% against today's price
- 4 buy or overweight
- 6 hold
- 1 underweight or sell
The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.
What it has traded at
What its sector has traded at
Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.
Every estimate on one scale
The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.